Sectra, Medtronic and Enovis: The Implementation Cost Behind Platform Growth – Sep 4, 2026
The cost of making a platform productive belongs inside its commercial strategy. It cannot be left as an assumption between market access and the expected return. Developments from August 29 through September 4 expose that cost at different stages. Sectra reports revenue from deployed cloud services. Medtronic is expanding robotics distribution options. Enovis proposes acquiring […]
Radiology Partners, 4DMedical and PanTera: Imaging Value Moves to Operating Control – August 28, 2026
The most consequential imaging developments of the week did not share a modality, product category or business model. They shared a control point. Radiology Partners moved to acquire international case flow. 4DMedical introduced a contract tied to minimum utilization. ImExHS tested workflow agents inside its own radiology-services operation. PanTera connected qualified actinium-225 supply to recurring […]
Pro Medicus, Vitestro and Radiobotics: Imaging AI Shifts to Operating Proof – August 21, 2026
Pro Medicus, Vitestro and Radiobotics show why imaging AI value now depends on activation, lifecycle evidence and renewal economics for providers and investors. 🎧 Listen to this week’s Marketstrat Pulse Insight: The strategic question in medical imaging and AI-enabled MedTech is changing. Regulatory authorization remains necessary, but it no longer provides enough evidence of commercial […]
Teledyne, RadNet, Heartflow and Aidoc Shift Medical Imaging Value Toward Monetization Control – August 14, 2026
Teledyne, RadNet, Heartflow and Aidoc show how imaging value is shifting toward component control, workflow, payment and repeat paid use. 🎧 Listen to this week’s Marketstrat Pulse Insight: Medical imaging companies have historically been judged by the assets they sell, the technologies they clear and the number of sites they reach. The stronger signals from […]
GE HealthCare, MARS Bioimaging, QT Imaging and Hyperfine Show Why Imaging Capacity Is Moving from Rooms to Networks – August 7, 2026
Medical imaging capacity is entering a new phase. Scanner count still matters, but it no longer provides a sufficient view of how much clinical work an imaging organization can complete. The more useful measure is productive capacity: the number of studies that move from referral and authorization through acquisition, interpretation, reporting and payment. This week’s […]
Caristo, DeepHealth, ThinkSono and 4DMedical Shift Imaging AI Toward Service-Line Economics – July 31, 2026
Medical imaging AI is entering a more demanding commercialization phase. Regulatory authorization, technical performance and access to a large study pool remain important. They do not establish market adoption on their own. The decisive question is conversion: how many eligible studies move through an activated workflow, produce a usable result, receive appropriate human review, meet […]
Johnson & Johnson, GE HealthCare, DeepHealth and CARPL.ai Shift Imaging AI Toward Decision Infrastructure – July 24, 2026
Johnson & Johnson, GE HealthCare, DeepHealth and CARPL.ai show imaging AI moving from model access to governed clinical action. Medical imaging AI is entering a more demanding phase of commercialization. Model availability continues to expand, but the strategic contest is moving to the infrastructure that converts technical output into a standardized, governed and completed clinical […]
CMS, GE HealthCare, Sectra and Provect AI Reshape Imaging Capacity – July 17, 2026
Marketstrat analyzes how CMS, GE HealthCare, Sectra and Provect AI are shifting imaging value toward capacity, workflow control and governance. 🎧 Listen to this week’s Marketstrat Pulse Insight: CMS, GE HealthCare, Sectra and Provect AI Signal a New Imaging Capacity-Control Market Medical imaging has traditionally evaluated value at the level of the asset or algorithm. […]
CMS, Heartflow, Cleerly, Viz.ai and Philips Reframe Imaging AI Economics – July 10, 2026
Marketstrat analyzes how CMS, Heartflow, Cleerly, Viz.ai and Philips are shifting imaging AI toward payment, workflow control and capacity. 🎧 Listen to this week’s Marketstrat Pulse Insight: Medical imaging AI is entering a more demanding stage of commercialization. Regulatory clearance still matters, but the week ending July 10, 2026 showed that payment architecture, workflow control […]
Aidoc, DeepHealth/RadNet, GuideAI and HOPPR Move Imaging AI Beyond Clearance – June 26, 2026
The week ending June 26 showed that imaging AI adoption now depends on workflow governance, platform layering, reimbursement, enterprise distribution and supply resilience. Imaging AI activity resumed across CT, MRI and mammography, but the week’s bigger signal was not clearance volume. Aidoc and HOPPR moved report drafting toward the next workflow frontier. DeepHealth/RadNet expanded mammography […]
